Page last updated: 2024-08-21

c.i. 42510 and Huntington Disease

c.i. 42510 has been researched along with Huntington Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Alberch, J; Canals, JM; Díaz-Hernández, M; Díez-Zaera, M; Gómez-Villafuertes, R; Lucas, JJ; Miras-Portugal, MT; Sánchez-Nogueiro, J	1

Other Studies

1 other study(ies) available for c.i. 42510 and Huntington Disease

Article	Year
Altered P2X7-receptor level and function in mouse models of Huntington's disease and therapeutic efficacy of antagonist administration. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2009, Volume: 23, Issue:6 Topics: Animals; Apoptosis; Calcium; Cell Survival; Cells, Cultured; Disease Models, Animal; Humans; Huntington Disease; Mice; Mice, Knockout; Neurons; Neuroprotective Agents; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2; Receptors, Purinergic P2X7; Rosaniline Dyes; Rotarod Performance Test; Synapses	2009

Article

Year

Altered P2X7-receptor level and function in mouse models of Huntington's disease and therapeutic efficacy of antagonist administration.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2009, Volume: 23, Issue:6

Topics: Animals; Apoptosis; Calcium; Cell Survival; Cells, Cultured; Disease Models, Animal; Humans; Huntington Disease; Mice; Mice, Knockout; Neurons; Neuroprotective Agents; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2; Receptors, Purinergic P2X7; Rosaniline Dyes; Rotarod Performance Test; Synapses

2009